CVE:MJN Cronos Group - MJN Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cronos Group Inc Please log in to your account or sign up in order to add this asset to your watchlist. C$12.15 -0.23 (-1.86%) (As of 03/2/2018) Add Compare Share Share Today's RangeC$11.90▼C$12.4750-Day RangeC$12.15▼C$12.1552-Week RangeC$1.58▼C$14.83Volume1.39 million shsAverage Volume2.07 million shsMarket CapitalizationC$1.73 billionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsInsider TradesHeadlinesOptions Chain About Cronos Group (CVE:MJN) StockCronos Group Inc, formerly PharmaCan Capital Corp, is a Canada-based cannabis company. The Company operates two Licensed Producers (LPs) regulated within Health Canada's Access to Cannabis for Medical Purposes Regulations (the ACMPR) and holds a portfolio of investments in other Licensed Producers and ACMPR applicants. Its LPs, Peace Naturals Project Inc. and In The Zone Produce Ltd., are collectively located on over 125 acres of agricultural land. It also holds equity positions in Licensed Producers Whistler Medical Marijuana, Hydropothecary and Abcann Medicinals. Whistler Medical Marijuana is licensed to produce and sell medical marijuana, as well as cultivate cannabis oil. Hydropothecary is licensed to produce medical marijuana. Abcann Medicinals also has license to produce medical marijuana. With interest in five Licensed Producers and two LP applicants, it is focused on building brand portfolio providing patients with personalized care.Read More Receive MJN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address MJN Stock News HeadlinesDecember 14, 2022 | marketwatch.comCronos Group Inc. stock outperforms market despite losses on the dayNovember 7, 2022 | marketwatch.comCronos Group Shares Decline on 3Q MissesJanuary 30, 2023 | Porter & Company (Ad)The Next Big Crisis Is HereYou just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.November 7, 2022 | benzinga.comWhy Cronos Group Shares Are Falling SharplyOctober 26, 2022 | marketwatch.comCronos Shares Fall 5.1% After Hours On SEC Charges for Alleged Accounting FraudOctober 25, 2022 | msn.comCronos Group, former exec agree to pay fines as part of settlement with OSCOctober 24, 2022 | benzinga.comWhat's Going On With Cronos Group Stock Falling During Monday's After-Hours SessionSeptember 21, 2022 | finance.yahoo.comCronos Group Inc. (CRON)January 30, 2023 | Porter & Company (Ad)Is This The End of Capitalism?EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…August 9, 2022 | msn.comRecap: Cronos Group Q2 EarningsAugust 9, 2022 | markets.businessinsider.comWhy Cronos Stock Is Getting Hammered TodayAugust 9, 2022 | msn.comWhy Cronos Group Is Plummeting TodayJune 27, 2022 | seekingalpha.comCronos partners with Geocann for leveraging VESIsorb delivery technology for faster absorptionJune 27, 2022 | markets.businessinsider.comCronos Partners With Geocann To Launch CBD Gel Capsules By Lord Jones Utilizing VESIsorb For Faster AbsorptionJune 21, 2022 | benzinga.comCronos Group And Ginkgo Bioworks Achieve Rare Cannabinoid THCV Equity MilestoneJune 21, 2022 | finance.yahoo.comCronos Group and Ginkgo Bioworks Announce Achievement of THCV Equity MilestoneMay 12, 2022 | seekingalpha.comCronos Group Inc.'s (CRON) CEO Mike Gorenstein on Q1 2022 Results - Earnings Call TranscriptMay 11, 2022 | msn.comIs Cronos Group (TSX:CRON) a Buy After its 1st-Quarter Performance?May 10, 2022 | seekingalpha.comCronos Group Inc. (CRON) CEO Mike Gorenstein on Q1 2022 Results - Earnings Call TranscriptOctober 27, 2021 | ca.finance.yahoo.comBig Tobacco and Major US Stock Exchange Approval Further Boost Cannabis Sector CredibilityJuly 26, 2021 | proactiveinvestors.comMGC Pharmaceuticals reports record quarterly sales - Proactive Investors USA & CanadaFebruary 25, 2021 | finance.yahoo.comEdited Transcript of RB.L earnings conference call or presentation 24-Feb-21 8:00am GMT - Yahoo FinanceMay 25, 2020 | www.bloomberg.comCronos Group Changes Canadian Ticker to CRONMay 22, 2020 | www.bloomberg.comCronos Group Files Q2 2017 Financial Results and Provides Operational UpdateMarch 22, 2020 | www.fool.caTSX:CRON (CRONOS GROUP)March 5, 2020 | www.fool.caTSX:AZ (ARMISTICE RESOURCES CORP.)February 11, 2020 | www.bloomberg.comCanadian Medical Cannabis Sector Leading the Charge in Marijuana Industry GrowthSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive MJN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE Industry Electronic Computer Manufacturing Sub-IndustryCannabis SectorManufacturing Current SymbolCVE:MJN CUSIPN/A CIKN/A Webthecronosgroup.com Phone+1-416-5040004FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares142,653,000Free FloatN/AMarket CapC$1.73 billion OptionableOptionable BetaN/A Key ExecutivesMichael Ryan GorensteinPresident, Chief Executive Officer, Vice Chairman of the Board, Corporate SecretaryWilliam Lawrence HilsonChief Financial OfficerJason AdlerDirectorRyan RoebuckDirectorJames RudykDirectorAlan Mark Friedman (Age 45)Independent Director Michael Howard KrestellIndependent DirectorMore ExecutivesKey CompetitorsCanniMed TherapeuticsTSE:CMEDParamount Resources TECTSE:TETSirius XM CanadaTSE:XSRCanyon Services GroupTSE:FRCSandvineTSE:SVCView All Competitors MJN Stock - Frequently Asked Questions How have MJN shares performed in 2023? Cronos Group's stock was trading at C$12.15 at the beginning of 2023. Since then, MJN stock has increased by 0.0% and is now trading at C$12.15. View the best growth stocks for 2023 here. Is Cronos Group a good dividend stock? Cronos Group (CVE:MJN) pays an annual dividend of C$1.65 per share and currently has a dividend yield of 0.00%. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Cronos Group (CRON), Aurora Cannabis (ACB), Canopy Growth (WEED), Organigram (OGI), Aphria (APHA), IMV (IMV), Leaf Mobile (LEAF), Aurora Cannabis (ACB) and CanniMed Therapeutics (CMED). What is Cronos Group's stock symbol? Cronos Group trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MJN." How do I buy shares of Cronos Group? Shares of MJN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Cronos Group's stock price today? One share of MJN stock can currently be purchased for approximately C$12.15. How much money does Cronos Group make? Cronos Group (CVE:MJN) has a market capitalization of C$1.73 billion. How many employees does Cronos Group have? The company employs 147,000 workers across the globe. How can I contact Cronos Group? Cronos Group's mailing address is 720 King St W Suite 320, TORONTO, ON M5V 2T3, Canada. The official website for the company is thecronosgroup.com. The company can be reached via phone at +1-416-5040004. This page (CVE:MJN) was last updated on 1/30/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.